Things I Wish I'd Known Before Starting Wegovy

Wegovy's most common side effects are gastrointestinal (nausea especially) and they are most likely to appear in the first days after starting or after a dose increase, not throughout treatment.
Titration is deliberate and slow: doses step up roughly every four weeks, guided by your prescriber, to give your body time to adjust.
The 2.4mg weekly injection was the standard maintenance dose; a higher 7.2mg option is now also MHRA-approved (April 2026) for adults with a BMI of 30 or above.
Wegovy is a prescription-only medicine — a clinician reviews your full medical picture before any treatment is prescribed, including any other medicines you take.

Before taking Wegovy, most people expect the hard part to be the injections. It isn't. The nausea, the slower pace of titration, the way your appetite changes before your habits do — those are the things that catch people off guard. Wegovy (semaglutide) is a once-weekly prescription injection licensed in the UK for weight management, and a prescriber has to assess whether it's clinically appropriate for you before treatment begins. This page covers the practical and clinical realities that are rarely spelled out in advance, drawn entirely from NHS guidance and the medicine's licensed evidence base.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The gaps between expectation and reality on Wegovy treatment

The biggest misconception: that the nausea means something is wrong

This is the one that sends people off-track earliest. Nausea after starting Wegovy, or after a dose step-up, is expected and documented. It is a direct consequence of how semaglutide works: it slows gastric emptying and acts on hunger-regulating signals in the brain, and your digestive system takes time to recalibrate. The NHS medicines page for semaglutide lists nausea as a common side effect alongside constipation, diarrhoea, vomiting and indigestion, and notes that these effects tend to ease as the body adjusts.

What catches people out is the timing. Nausea often peaks not when you first inject but in the twelve to twenty-four hours that follow, and it can flare again with each new dose level. That is not a sign the medicine is failing or that something has gone wrong. It is the titration schedule doing its job. Small, frequent meals, plain foods, and staying hydrated are the practical tools, but your prescriber is the right person to discuss this with if the symptoms are stopping you from eating adequately or are persisting longer than expected.

Severe or persistent stomach pain that radiates to your back is different, and warrants urgent medical attention: in January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known though infrequent risk with GLP-1 medicines. That update is worth knowing about before you start.

The weight loss is slower than the headlines suggest, and that is fine

Trial data reported in the STEP 1 study, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks in adults taking 2.4mg semaglutide weekly alongside lifestyle support. That is a meaningful figure. It is also a 68-week figure, covering more than a year, measured at a population average.

In practice, the early weeks often feel underwhelming. You are on the starter dose, which is designed to settle your system rather than produce significant weight reduction. Many people see little change in the first month and assume the medicine is not working. It is almost always too soon to judge. The therapeutic effect builds as the dose increases and as the medicine reaches steady state, typically after several months on the maintenance dose. If you want a clearer sense of what progress can realistically look like over time, our Wegovy before and after page brings together what the evidence and real-world experience suggest at each stage.

It is also worth knowing that the trial evidence covers Wegovy used alongside a reduced-calorie diet and increased physical activity. The medicine does not work in isolation. Most people find their appetite falls noticeably, which makes dietary changes more manageable, but the lifestyle component matters. If you want to understand the cost picture before starting, our Wegovy pricing page sets out what a private prescription typically involves in the UK.

Oral contraceptives, other medicines, and timing matter more than you might expect

Because Wegovy slows the movement of food through the stomach, it can affect how other medicines are absorbed. This is not a reason to panic, but it is a reason to tell your prescriber about every medicine and supplement you take before you start. Your full medication list is part of what a prescriber reviews.

One specific interaction is worth flagging: NHS guidance notes that semaglutide does not carry the same evidence of reduced oral contraceptive pill absorption as tirzepatide does, but this is still an area to raise with your prescriber, especially if you are switching from one GLP-1 to another. Pregnancy is not compatible with Wegovy treatment; the medicine is not recommended for anyone who is pregnant, breastfeeding, or actively trying to conceive.

Timing in another sense also matters. If you are starting treatment around a holiday, a surgical procedure, or any period where your routine will be disrupted, tell your clinical team in advance. Injecting on an unusual day, travelling across time zones, or going under general anaesthetic all have practical implications your prescriber should know about. Our page covering what to do before taking Wegovy is worth going through carefully rather than treating as a formality. Similarly, if you have wondered whether taking Wegovy before bed could help reduce nausea or simply fits your schedule better, our prescribers field that question regularly and the answer is more nuanced than most people expect.

It is a prescription medicine, and the clinical assessment is the safeguard

Wegovy is a prescription-only medicine in the UK. That legal status exists because the risk-benefit balance depends on individual clinical factors, weight, medical history, other conditions, other medicines. No legitimate route to it bypasses a prescriber.

At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, reading your answers, your medication history, and the supporting information you provide. Your pen is then dispensed from our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register). That review happens the same day for orders placed before 12pm on a working day, with free next-working-day delivery via DPD once approved. There is no algorithm making the prescribing decision.

A prescriber can also help you think through what to expect, which is, in a lot of cases, the most useful conversation to have before you start. If you are weighing up whether Wegovy is the right route, our weight-loss treatment overview covers both Wegovy and the other licensed options available. When you are ready to talk to a clinician about your own situation, you can start a free consultation at any point.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions